Gerstein HC - Search Results

1

Dual inhibition of the renin-angiotensin system in high-risk diabetes and risk for stroke and other outcomes: results of the ONTARGET trial.

Mann JF, Anderson C, Gao P, Gerstein HC, Boehm M, Rydén L, Sleight P, Teo KK, Yusuf S; ONTARGET investigators. Mann JF, et al. Among authors: gerstein hc. J Hypertens. 2013 Feb;31(2):414-21. doi: 10.1097/HJH.0b013e32835bf7b0. J Hypertens. 2013. PMID: 23249829 Clinical Trial.

2

Summary of randomized trials of angiotensin converting enzyme inhibitors.

Yusuf S, Lonn E, Bosch J, Gerstein H. Yusuf S, et al. Clin Exp Hypertens. 1999 Jul-Aug;21(5-6):835-45. doi: 10.3109/10641969909061013. Clin Exp Hypertens. 1999. PMID: 10423106 Review.

3

Ramipril and the development of diabetes.

Yusuf S, Gerstein H, Hoogwerf B, Pogue J, Bosch J, Wolffenbuttel BH, Zinman B; HOPE Study Investigators. Yusuf S, et al. JAMA. 2001 Oct 17;286(15):1882-5. doi: 10.1001/jama.286.15.1882. JAMA. 2001. PMID: 11597291 Clinical Trial.

4

Effects of vitamin E on cardiovascular and microvascular outcomes in high-risk patients with diabetes: results of the HOPE study and MICRO-HOPE substudy.

Lonn E, Yusuf S, Hoogwerf B, Pogue J, Yi Q, Zinman B, Bosch J, Dagenais G, Mann JF, Gerstein HC; HOPE Study; MICRO-HOPE Study. Lonn E, et al. Among authors: gerstein hc. Diabetes Care. 2002 Nov;25(11):1919-27. doi: 10.2337/diacare.25.11.1919. Diabetes Care. 2002. PMID: 12401733 Clinical Trial.

5

The relationship between dysglycemia and atherosclerosis in South Asian, Chinese, and European individuals in Canada: a randomly sampled cross-sectional study.

Gerstein HC, Anand S, Yi QL, Vuksan V, Lonn E, Teo K, Malmberg K, McQueen M, Yusuf S; SHARE Investigators. Gerstein HC, et al. Diabetes Care. 2003 Jan;26(1):144-9. doi: 10.2337/diacare.26.1.144. Diabetes Care. 2003. PMID: 12502671

6

Diagnostic strategies to detect glucose intolerance in a multiethnic population.

Anand SS, Razak F, Vuksan V, Gerstein HC, Malmberg K, Yi Q, Teo KK, Yusuf S. Anand SS, et al. Among authors: gerstein hc. Diabetes Care. 2003 Feb;26(2):290-6. doi: 10.2337/diacare.26.2.290. Diabetes Care. 2003. PMID: 12547851

7

Development of renal disease in people at high cardiovascular risk: results of the HOPE randomized study.

Mann JF, Gerstein HC, Yi QL, Lonn EM, Hoogwerf BJ, Rashkow A, Yusuf S. Mann JF, et al. Among authors: gerstein hc. J Am Soc Nephrol. 2003 Mar;14(3):641-7. doi: 10.1097/01.asn.0000051594.21922.99. J Am Soc Nephrol. 2003. PMID: 12595499 Clinical Trial.

8

Cardiovascular risk in patients with mild renal insufficiency.

Mann JF, Gerstein HC, Dulau-Florea I, Lonn E. Mann JF, et al. Among authors: gerstein hc. Kidney Int Suppl. 2003 May;(84):S192-6. doi: 10.1046/j.1523-1755.63.s84.27.x. Kidney Int Suppl. 2003. PMID: 12694342 Free article. Review.

9

Progression of renal insufficiency in type 2 diabetes with and without microalbuminuria: results of the Heart Outcomes and Prevention Evaluation (HOPE) randomized study.

Mann JF, Gerstein HC, Yi QL, Franke J, Lonn EM, Hoogwerf BJ, Rashkow A, Yusuf S; HOPE Investigators. Mann JF, et al. Among authors: gerstein hc. Am J Kidney Dis. 2003 Nov;42(5):936-42. doi: 10.1016/j.ajkd.2003.07.015. Am J Kidney Dis. 2003. PMID: 14582037 Clinical Trial.

10

Cardiovascular risk in patients with early renal insufficiency: implications for the use of ACE inhibitors.

Mann JF, Gerstein HC, Pogue J, Lonn E, Yusuf S. Mann JF, et al. Among authors: gerstein hc. Am J Cardiovasc Drugs. 2002;2(3):157-62. doi: 10.2165/00129784-200202030-00003. Am J Cardiovasc Drugs. 2002. PMID: 14727978 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

438 results

Search Page